Markets
Stocks
Mutual Funds & ETFs
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
TG Therapeutics, Inc.
(OB:
TGTX
)
6.570
USD
UNCHANGED
Last Price
/ Updated:
8:10 PM EDT, May 29, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
6.570
Today's Range
6.570 - 6.570
52wk Range
2.150 - 6.730
Shares Outstanding
26,322,671
Dividend Yield
N/A
Performance
YTD
+77.57%
+77.57%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+192.00%
+192.00%
Top News
More News
TG Therapeutics, Inc. Announces Presentation of Encouraging Clinical Activity of TGR-1202 in an Ongoing Multi-Center Phase I Clinical Study
December 09, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. Launches Combination Clinical Trial of TG-1101 and Ibrutinib in Patients With Select B-Cell Malignancies
December 06, 2013
Combination Trial Led by Jeff Sharman, MD, Medical Director Hematology Research, US Oncology and Owen A. O'Connor, MD, PhD, Director of the Center for Lymphoid Malignancies, Columbia University Medical...
Read More
from
GlobeNewswire News Releases
More News
Read More
TG Therapeutics, Inc. Announces Poster Presentations for TGR-1202 at the Upcoming 55th American Society of Hematology Meeting
December 05, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Present at the 2013 Deutsche Bank BioFEST Conference
November 26, 2013
from
GlobeNewswire News Releases
TG Therapeutics to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013
November 11, 2013
from
ACCESSWIRE
TG Therapeutics, Inc. Initiates First Combination Clinical Trial of TG-1101 and TGR-1202 in Patients With Relapsed and/or Refractory CLL and NHL
November 25, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. Announces Third Quarter 2013 Financial Results and Business Update
November 11, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2013 Financial Results and Business Update
November 08, 2013
from
GlobeNewswire News Releases
TG Therapeutics (TGTX) Reports Significant Data from TGR-1202 Phase I in NHL
December 09, 2013
from
StreetInsider.com News Articles
TG Therapeutics Says TGR-1202 Appears Well Tolerated, Grade 3 Events Have Been Limited
December 09, 2013
category
TGTX
,
Benzinga
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
TG Therapeutics Presents Encouraging TGR-1202 Data at ASH
December 09, 2013
category
TGTX
,
Management
,
Benzinga
, and 4 more.
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here